Established and Emerging Cancer Therapies and Cardiovascular System: Focus on Hypertension—Mechanisms and Mitigation

LE Butel-Simoes, TJ Haw, T Williams, S Sritharan… - …, 2023 - Am Heart Assoc
Cardiovascular disease and cancer are 2 of the leading causes of death worldwide.
Although improvements in outcomes have been noted for both disease entities, the success …

The relationship between metabolic dysfunction-associated fatty liver disease and the incidence rate of extrahepatic cancer

S Wei, Y Hao, X Dong, J Huang, K Huang… - Frontiers in …, 2023 - frontiersin.org
Background The associations between metabolic dysfunction-associated fatty liver disease
(MAFLD) and cancer development, especially extrahepatic cancers, are unknown. The aims …

Néphroprotection: principes généraux et application au patient de cancérologie–quand la protection du rein est indispensable à la bonne conduite du plan de soin …

M Bainaud, M Try, M Zaidan - Bulletin du Cancer, 2023 - Elsevier
Résumé La néphroprotection consiste en l'ensemble des recommandations qui ont pour
objectifs de prévenir les risques d'insuffisance rénale aiguë et/ou chronique et de limiter la …

The antihypertensive felodipine shows synergistic activity with immune checkpoint blockade and inhibits tumor growth via NFAT1 in LUSC

SY Liang, HK Xiao - Open Medicine, 2023 - degruyter.com
This study aimed to explore the role and mechanism of felodipine in lung cancer therapy.
Murine subcutaneous lung squamous cancer (LUSC) models constructed by KLN-205 cells …

Verapamil modulates NFAT2 to inhibit tumor growth and potentiates PD1ab immune checkpoint inhibitor therapy in cervical cancer treatment

YQ Liao, BB Fang, QX Wu, WY Dong… - Journal of Receptors …, 2023 - Taylor & Francis
Purpose Current evidence suggests a high co-prevalence of hypertension and cervical
cancer. Accordingly, blood pressure control is indicated during anti-tumor drug therapy in …